R-CHOP/Ibrutinib Alternating with R-DHAX Regimen

Preferred Label : R-CHOP/Ibrutinib Alternating with R-DHAX Regimen;

NCIt synonyms : R-CHOP-Ibrutinib Alternating with R-DHAX; R-CHOP-Ibrutinib/R-DHAX; R-CHOP-Ibrutinib/R-DHAX Regimen; Cyclophosphamide/Doxorubicin/Prednisone/Rituximab/Vincristine Plus Ibrutinib Alternating with Rituximab Plus Cytarabine/Dexamethasone/Oxaliplatin; Cyclophosphamide/Doxorubicin/Prednisone/Rituximab/Vincristine/Ibrutinib-Rituximab/Cytarabine/Dexamethasone/Oxaliplatin;

NCIt related terms : IR-CHOP/R-DHAOx (rituximab-rixa); IR-CHOP/R-DHAOx (rituximab-abbs); IR-CHOP/R-DHAOx (rituximab-arrx); IR-CHOP/R-DHAOx (rituximab-pvvr); IR-CHOP/R-DHAOx (rituximab-rite); IR-CHOP/R-DHAOx (rituximab-rixi); IR-CHOP/R-DHAOx; IR-CHOP/R-DHAOx (rituximab-blit);

NCIt definition : A regimen that alternates rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone (R-CHOP) and ibrutinib with rituximab, dexamethasone, high-dose cytarabine and oxaliplatin (R-DHAX) that can be used for the treatment of mantle cell lymphoma (MCL).;

Codes from synonyms : 140713; 140712; 140715; 140714; 140717; 140716; 140719; 140718;

Détails

Origin ID

C210786;

chemotherapy_regimen_has_component
- Cyclophosphamide [NCIt concept]
- Cytarabine [NCIt concept]
- Dexamethasone [NCIt concept]
- Doxorubicin Hydrochloride [NCIt concept]
- Ibrutinib [NCIt concept]
- Oxaliplatin [NCIt concept]
- Prednisone [NCIt concept]
- Rituximab [NCIt concept]
- Vincristine Sulfate [NCIt concept]
concept_is_in_subset
- HemOnc Regimen Terminology [NCIt concept]
- Multi-agent Therapeutic Regimens [NCIt concept]
- Pharmacotherapy Regimens [NCIt concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients